BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/12/2021 12:42:13 AM | Browse: 470 | Download: 758
 |
Received |
|
2021-03-16 15:04 |
|
Peer-Review Started |
|
2021-03-16 15:23 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-01 16:09 |
|
Revised |
|
2021-05-09 16:48 |
|
Second Decision |
|
2021-06-16 13:40 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-06-16 14:00 |
|
Articles in Press |
|
2021-06-16 14:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-06-26 02:45 |
|
Typeset the Manuscript |
|
2021-07-06 13:14 |
|
Publish the Manuscript Online |
|
2021-07-12 00:42 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Frontier |
| Article Title |
Liver dysfunction and SARS-CoV-2 infection
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Abraham Edgar Gracia-Ramos, Joel Omar Jaquez-Quintana, Raúl Contreras-Omaña and Moises Auron |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Abraham Edgar Gracia-Ramos, MD, MSc, N/A, Department of Internal Medicine, General Hospital, National Medical Center "La Raza", Instituto Mexicano del Seguro Social, Av. Jacaranda S/N, Col. La Raza, Del. Azcapotzalco, C.P., Mexico City 02990, Mexico. dr.gracia.dmm@gmail.com |
| Key Words |
SARS-CoV-2; Coronavirus; COVID-19; Liver; Liver diseases; Liver failure; Liver injury; Cirrhosis |
| Core Tip |
Coronavirus disease 2019 (COVID-19)-associated liver injury is defined as any liver damage occurring during the disease course and treatment of COVID-19 in patients with or without pre-existing liver disease, with an observed ratio of 1:5. The presence of abnormal liver biochemical parameters has been associated with a severe course of severe acute respiratory syndrome coronavirus 2 infection and other complications, including death. Pathophysiology of COVID-19-induced liver injury is complex. Also, special consideration should be made in patients with pre-existing liver disease, such as metabolic dysfunction-associated fatty liver disease, chronic liver disease due to viral or autoimmune disease, liver transplant carriers, or cirrhosis. |
| Publish Date |
2021-07-12 00:42 |
| Citation |
Gracia-Ramos AE, Jaquez-Quintana JO, Contreras-Omaña R, Auron M. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol 2021; 27(26): 3951-3970 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i26/3951.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i26.3951 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
